Literature DB >> 13518279

Host resistance to hemorrhagic shock. XI. Role of deficient flow through intestine in development of irreversibility.

P B SHAPIRO, B BRONSTHER, E D FRANK, J FINE.   

Abstract

Entities:  

Keywords:  INTESTINES/blood supply

Mesh：

Year:  1958        PMID： 13518279     DOI： 10.3181/00379727-97-23747

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  8 in total

1.  CAUSES OF DEATH IN MESENTERIC ARTERIAL OCCLUSION. II. OBSERVATIONS ON REVASCULARIZATION OF THE ISCHEMIC BOWEL.

Authors:  A MARSTON
Journal:  Ann Surg       Date:  1963-12       Impact factor: 12.969

2.  Patterns of Intestinal Ischaemia: Arris and Gale Lecture delivered at the Royal College of Surgeons of England on 6th February 1964.

Authors:  A Marston
Journal:  Ann R Coll Surg Engl       Date:  1964-09       Impact factor: 1.891

3.  Studies on the mechanism of shock. Failure to find a role for intestinal bacterial endotoxin in burn shock.

Authors:  R A Little; H B Stoner
Journal:  Br J Exp Pathol       Date:  1972-08

4.  [164. Intestinal factors in shock: enterotoxines].

Authors:  U F Gruber
Journal:  Langenbecks Arch Chir       Date:  1967

5.  Effect of intraluminal oxygen on experimental ischaemia of the intestine.

Authors:  K Shute
Journal:  Gut       Date:  1976-12       Impact factor: 23.059

6.  Effect of celiac blockade and dibenzyline on traumatic shock following release of occluded superior mesenteric artery.

Authors:  A Nahor; J Milliken; J Fine
Journal:  Ann Surg       Date:  1966-01       Impact factor: 12.969

7.  On the relation of the size of the intraintestinal pool of endotoxin to the development of irreversibility in hemorrhagic shock.

Authors:  T WIZNITZER; F B SCHWEINBURG; N ATKINS; J FINE
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

8.  Pathogenesis of experimental shock. III. A lethal factor in the blood of rabbits following occlusion of the superior mesentric artery.

Authors:  A JANOFF; A L NAGLER; S BAEZ; B W ZWEIFACH
Journal:  J Exp Med       Date:  1961-08-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.